CARA.ST Carasent ASA

Healthcare Health Information Services Stockholm Exchange
25.60 SEK
Close of Nov 7, 2026
21.70 29.45
Market cap
SEK 1.73B
P/E
43.4x
P/B
2.14x
ROE
1.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CARA.ST undervalued?

Graham number
Price25.60
Graham value12.59
Premium103.3%

CARA.ST trades 103.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Carasent ASA fundamental analysis

No fundamental analysis for Carasent ASA yet.

Carasent ASA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Carasent ASA

Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is head…

Full company profile